Table III. Metalloproteinase levels in each treatment group.
C: Control; APAP: acetaminophen administration; APAP+S: APAP and silymarin administration as pretreatment; APAP+LCC1: APAP and pretreatment with 1 mg/100 g bw LCC; APAP+LCC2: APAP and pretreatment with 2 mg/100 g bw LCC; Std: standard deviation; MMP-2: matrix matalloproteinase-2; MMP-9: matrix metalloproteinase-9.
